Tuesday, August 24, 2021

Hidden conflicts? Pharma payments to FDA advisers after drug approvals spark ethical concerns

On a sweltering July day in 2010, seven medical researchers and one patient advocate gathered in a plush Marriott hotel in College Park, Maryland, to review a promising drug designed to prevent heart attacks and strokes by limiting blood clotting.